Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/pretiorates-thoughts-72-how-sharp-are-the-bears-claws/